Coronary vasoregulation in health and disease

Canadian Journal of Cardiology

Volumn 23, Issue SUPPL. B, 2007, Pages 9B-14B

  Kingma Jr , John G ^a   Rouleau, Jacques R ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Autoregulation; Cardiac nervous system; Ischemia reperfusion injury; Ischemic preconditioning; Myocardial blood flow; Vasoregulation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN; TRANDOLAPRIL; VERAPAMIL;

ACUTE HEART INFARCTION; ANGINA PECTORIS; AUTOREGULATION; CANADA; CELL DAMAGE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY BLOOD VESSEL; DIASTOLIC BLOOD PRESSURE; HEALTH CARE FACILITY; HEART FUNCTION; HEART INNERVATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART TRANSPLANTATION; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; KIDNEY FAILURE; MEDICAL RESEARCH; NEUROMODULATION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SPINAL CORD STIMULATION; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 35448996980     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0828-282x(07)71005-x     Document Type: Review

References (82)

1. Rouleau JR, Roy L, Dumesnil JG, Dagenais GR. Coronary vasodilator reserve impairment distal to systolic coronary artery compression in dogs. Cardiovasc Res 1983;17:96-105.
2. Bourassa MG, Butnaru A, Lespérance J, Tardif JC. Symptomatic myocardial bridges: Overview of ischemic mechanisms and current diagnostic and treatment strategies. J Am Coll Cardiol 2003;41:351-9.
3. Rouleau JR, White M. Effects of coronary sinus pressure elevation on coronary blood flow distribution in dogs with normal preload. Can J Physiol Pharmacol 1985;63:787-97.
4. Cantin B, Rouleau JR. Myocardial tissue pressure and blood flow during coronary sinus pressure modulation in anesthetized dogs. J Appl Physiol 1992;73:2184-91.
5. Ilbawi MN, Idriss FS, Muster AJ, et al. Effects of elevated coronary sinus pressure on left ventricular function after the Fontan operation. An experimental and clinical correlation. J Thorac Cardiovasc Surg 1986;92:231-7.
6. Kingma JG Jr, Martin J, Rouleau JR. Acute tamponade alters subendo- and subepicardial pressure-flow relations differently during vasodilation. Am J Physiol 1994;267:H133-8.
7. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
8. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
9. Cruickshank JM. Antihypertensive treatment and the J-curve. Cardiovasc Drugs Ther 2000;14:373-9.
10. Benetos A, Thomas F, Safar ME, Bean KE, Guize L. Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: A study in middle-aged men and women. J Am Coll Cardiol 2001;37:163-8.
11. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al; INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatiment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA 2003;290:2805-16.
12. Berl T, Hunsicker LG, Lewis JB, et al; The Collaborative Study Group. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 2005;16:2170-9.
13. Rouleau JR, Simard D, Blouin A, Kingma JG Jr. Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrohy. Basic Res Cardiol 2002;97:384-91.
14. Freeman RV, Mehta RH, Al Badr W, Cooper JV, Kline-Rogers E, Eagle KA. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/ IIIa inhibitors. J Am Coll Cardiol 2003;41:718-24.
15. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95.
16. Zanchetti A, Stella A. Cardiovascular disease and the kidney: An epidemiologic overview. J Cardiovasc Pharmacol 1999;33(Suppl 1):S1-6.
17. Rouleau JR, Dagnault A, Simard D, et al. Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits. Am J Physiol Heart Circ Physiol 2001;281:H1407-12.
18. Kingma JG, Vincent C, Rouleau JR, Kingma I. Influence of acute renal failure on coronary vasoregulation in dogs. J Am Soc Nephrol 2006;17:1316-24.
19. Gray AL, Johnson TA, Ardell JL, Massari VJ. Parasympathetic control of the heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate. J Appl Physiol 2004;96:2273-8.
20. Rouleau JR, Simard D, Rodrigue N, Blouin A, Kingma JG. Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: Effects of ACE-inhibition. Auton Neurosci 2002;97:12-8.
21. Tona F, Caforio AL, Montisci R, et al. Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation 2006;114(1 Suppl):149-55.
22. Mehta JL, Nichols WW, Donnelly WH, Lawson DL, Saldeen TG. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion. Circ Res 1989;64:43-54.
23. Vanhaecke J, Flameng W, Borgers M, Jang IK, Van de Werf F, De Geest H. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res 1990;67:1201-10.
24. Nichols WW, Mehta JL, Donnelly WH, Lawson D, Thompson L, tar Riet M. Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: Role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins. J Mol Cell Cardiol 1998;20:943-54.
25. Bolli R, Triana JF, Jeroudi MO. Prolonged impairmant of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning". Circ Res 1990;67:332-43.
26. Kalweit GA, Schipke JD, Godehardt E, Gams E. Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin. J Thorac Cardiovasc Surg 2001;122:1011-8.
27. Kingma JG Jr, Denniss AR, Yellon DM. Influence of allopurinol plus verapamil treatment on myocardial tissue necrosis during permanent coronary occlusion in canine hearts with small infarcts. J Cardiovasc Pharmacol 1989;14:6-13.
28. Kingma JG, Miura T, Downey JM, Hearse DJ, Yellon DM. Myocardial salvage with allopurinol during 24 h of permanent coronary occlusion: Importance of pretreatment. Can J Cardiol 1988;4:360-5.
29. Denniss AR, Kingma JG Jr, Hearse DJ, Downey JM, Yellon DM. Long acting calcium antagonist anipamil limits myocardial necrosis and penetrates the ischemic zone during 24 h of coronary artery occlusion in the dog. Can J Cardiol 1990;6:31-7.
30. Werns SW, Grum CM, Ventura A, et al. Xanthine oxidase inhibition does not limit canine infarct size. Circulation 1991;83:995-1005.
31. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation 1983;68:18-15.
32. Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2002;282:H766-72.
33. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62.
34. Braunwald E, Kloner RA. The stunned myocardium:prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
35. Braunwald E, Kloner RA. Myocardial reperfusion: A double-edged sword? J Clin Invest 1985;76:1713-9.
36. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: Should the paradigm be expanded? Circulation 1989;79:441-4.
37. Ganz W, Watanabe I, Kanamasa K, Yano J, Han DS, Fishbein MC. Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia - half reperfused and half not reperfused. Circulation 1990;82:1020-33.
38. Ganz W. The quest for the ideal reperfusion strategy continues. Circulation 1991;83:1818-21.
39. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
40. Cribier A, Korsatz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study. J Am Coll Cardiol 1992;20:578-86.
41. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic and metabolic features. Circulation 1990;82:2044-51.
42. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994;24:1133-42.
43. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993;72:1293-9.
44. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-72.
45. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52.
46. Cohen MV, Downey JM. Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. J Mol Cell Cardiol 1996;27:1623-32.
47. Downey JM, Cohen MV. Signal transduction in ischemic preconditioning. Z Kardiol 1995;84(Suppl 4):77-86.
48. Qiu Y, Tang XL, Park SW, Sun JZ, Kalya A, Bolli R. The early and late phases of ischemic preconditioning. A comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. Circ Res 1997;80:730-42.
49. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991;84:341-9.
50. DeFily DV, Chilian WM. Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am J Physiol 1993;265:H700-6.
51. Bauer B, Simkhovich BZ, Kloner RA, Przyklenk K. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury? Circulation 1993;88:659-72.
52. Laude K, Beauchamp P, Thuillez C, Richard V. Endothelial protective effects of preconditioning. Cardiovasc Res 2002;55:466-73.
53. Laude K, Thuillez C, Richard V. Coronary endothelial dysfunction after ischemia and reperfusion: A new therapeutic target? Braz J Med Biol Res 2001;34:1-7.
54. Richard V, Kaeffer N, Hogie M, Tron C, Blanc T, Thuillez C. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: Studies with bosentan, a mixed ETA-ETB antagonist. Br J Pharmacol 1994;113:869-76.
55. Rubino A, Yellon DM. Ischaemic preconditioning of the vasculature: An overlooked phenomenon for protecting the heart? Trends Pharmacol Sci 2000;21:225-30.
56. Baxter GF, Yellon DM. Delayed myocardial protection following ischaemic preconditioning. Basic Res Cardiol 1996;91:53-6.
57. Yellon DM, Baxter GF. A "second window of protection" or delayed preconditioning phenomenon: Future horizons for myocardial protection? J Mol Cell Cardiol 1995;27:1023-34.
58. Kingma JG Jr. Cardiac adaptation to ischemia-reperfusion injury. Ann NY Acad Sci 1999;874:83-99.
59. Boudriau S, Daleau P, Bergeron C, Sénéhal G, Kingma JG Jr. Stability of the cytoskeleton contributes to preconditioning-induced cardioprotection. Can J Cardiol 1998;14(Suppl F):121F. (Abst 161)
60. Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M, Tada M. Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J Biol Chem 1998;273:12725-31.
61. Daleau P, Boudriau S, Michaud M, Jolicoeur C, Kingma JG. Preconditioning in the absence or presence of sustained ischemia modulates myocardial Cx43 protein levels and gap junction distribution. Can J Physiol Pharmacol 2001;79:371-8.
62. Bogaty P, Kingma JG, Guimond J, et al. Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon. J Am Coll Cardiol 2001;37:463-9.
63. Bogaty P, Kingma JG, Robitaille NM, et al. Attenuation of myocardial ischemia with repeated exercise in subjects with chronic stable angina: Relation to myocardial contractility, intensity of exercise and the adenosine triphosphate-sensitive potassium channel. J Am Coll Cardiol 1998;32:1665-71.
64. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: Recent advances and future perspectives. Vascul Pharmacol 2005;42:211-8.
65. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-88. (Erratum in 2004;286:H477).
66. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996;94:2193-200.
67. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002;106:2881-3.
68. Dickson EW, Lorbar M, Porcaro WA, et al. Rabbit heart can be "preconditioned" via transfer of coronary effluent. Am J Physiol 1999;277:H2451-7.
69. Przyklenk K, Darling CE, Dickson EW, Whittaker P. Cardioprotection 'outside the box' - the evolving paradigm of remote preconditioning. Basic Res Cardiol 2003;98:149-57.
70. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000;278:H1571-6.
71. Cardinal R, Ardell JL, Linderoth B, Vermeulen M, Foreman RD, Armour JA. Spinal cord activation differentially modulates ischaemic electrical responses to different stressors in canine ventricles. Auton Neurosci 2004;111:37-47.
72. Tallaj J, Wei CC, Hankes GH, et al. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation. Circulation 2003;108:225-30.
73. Gray AL, Johnson TA, Ardell JL, Massari VJ. Parasympathetic control of the heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate. J Appl Physiol 2004;96:2273-8.
74. Liem DA, Verdouw PD, Ploeg H, Kazim S, Duncker DJ. Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol Heart Circ Physiol 2002;283:H29-37.
75. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: Role of the autonomic nervous system. J Am Coll Cardiol 2005;46:450-6.
76. Dawn B, Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci 2002;962:18-41.
77. Baxter GF. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res 2002;55:483-94.
78. Foreman RD, Linderoth B, Ardell JL, et al. Modulation of intrinsic cardiac neurons by spinal cord stimulation: Implications for its therapeutic use in angina pectoris. Cardiovasc Res 2000;47:367-75.
79. Southerland EM, Milhom DM, Foreman RD, et al. Preemptive, but not reactive, spinal cord stimulation mitigates transient ischemia-induced myocardial infarction via cardiac adrenergic neurons. Am J Physiol Heart Circ Physiol 2007;292:H311-7.
80. Kingma JG Jr, Linderoth B, Ardell JL, Armour JA, DeJongste MJ, Foreman RD. Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia. Auton Neurosci 2001;91:47-54.
81. Jones CE, Devous MD, Thomas JX, DuPont E. The effect of chronic cardiac denervation on infarct size following acute coronary occlusion. Am Heart J 1978;95:738-46.
82. Rouleau J, Boerboom LE, Surjadhana A, Hoffman JI. The role of autoregulation and tissue diastolic pressures in the transmural distribution of left ventricular blood flow in anesthetized dogs. Circ Res 1979;45:804-15.